4.6 Review

miR-197: A novel biomarker for cancers

Journal

GENE
Volume 591, Issue 2, Pages 313-319

Publisher

ELSEVIER
DOI: 10.1016/j.gene.2016.06.035

Keywords

MicroRNA; miR-197; Biomarker; Cancer

Funding

  1. National Natural Science Foundation of China [81272470]

Ask authors/readers for more resources

microRNAs (miRNAs) are small noncoding RNAs that could regulate post-transcription level through binding to 3'untranslated region (3'UTR) of target messenger RNAs (mRNAs), which were reported to be related with the incidence and development of diverse neoplasms. Among them, miR-197 was confirmed to play a vital role of oncogene or anti-oncogene in different cancers via targeting key tumorigenic or tumor-suppressive genes. Additionally, miR-197 had extensively been studied in carcinogenesis progression of cancers through various mechanisms, including apoptosis, proliferation, angiogenesis, metastasis, drug resistance and tumor suppressor, and also played a role in prognosis of cancers. In this review, we summarized the roles of miR-197 in cancers and considered it as a potentially novel biomarker for different cancers, offering an alternatively secure and effective tool in molecular targeting cancer treatment. (C) 2016 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available